Wizard Platform for Prior Authorization Letters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating letters of medical necessity, appeals, or requests for formulary exceptions for prescriptions are inefficient and time-consuming, often resulting in inconsistent results due to information overload and the inability to tailor letters specifically to a patient's needs, leading to difficulties in accessing medically important therapies.
Innovation Solution
A digital platform that uses a wizard-style, step-by-step input system to streamline the process of creating customized letters by selecting appropriate form types, gathering and optimizing patient data from various databases, and verifying information to ensure compliance, thereby reducing the burden on prescribers and improving access to medical care.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If providers manually write letters of medical necessity, appeals, or requests for formulary exceptions, then they can customize the content to specific patient needs, but the process is time-consuming and inefficient
Solution Approach 1:
The system pre-creates letter templates with standardized structures and content frameworks that are optimized for specific pharmaceuticals and insurance requirements. These templates are prepared in advance with placeholders for patient-specific information, allowing providers to simply fill in relevant details rather than writing from scratch, thus reducing time while maintaining customization.
Solution Approach 2:
The system introduces a digital intermediary platform that mediates between the provider's patient information and the required letter format. This intermediary automatically extracts relevant patient data, selects appropriate template sections, and assembles the final letter, eliminating the need for manual writing while ensuring both customization and efficiency.
2Productivity
If providers use existing letter templates, then letter creation becomes faster, but the templates are too complicated and difficult to delegate to staff
Solution Approach 1:
The letter creation process is segmented into distinct, manageable components within the template system. Each template is divided into modular sections (patient information, medical history, treatment rationale, etc.) that can be independently filled and verified. This segmentation allows staff members to be trained on specific sections and assigned appropriate tasks, making delegation feasible while maintaining overall efficiency.
3Reliability
If the system collects comprehensive patient information from multiple databases, then letter quality and compliance improve, but information overload increases
Solution Approach 1:
The system extracts only the specific pieces of patient information needed for each letter type from the comprehensive database. Instead of presenting all available data, the system selectively pulls relevant fields (e.g., diagnosis codes, treatment history, lab results) based on the letter's purpose and the pharmaceutical's requirements, thereby reducing information overload while maintaining completeness for compliance.
Solution Approach 2:
Different portions of the system handle information differently based on local requirements. The template engine applies specific filters and transformations to different sections of patient data depending on the letter type and insurance provider requirements, ensuring that each section receives the appropriate level of detail and processing needed for its specific purpose.
Data Source
AI summary
The present invention relates generally to health care prescription authorization. Particularly, the present invention relates to a method of preparing a prior authorization request, an appeal, or request for formulary exception for prescriptions for a patient capable of being tailored for a specific pharmaceutical with a specific utilization management criteria, with a verification protocol with an optimization protocol, for a specific pharmaceutical, for a specific purpose, with specific tips to address concerns of the insurers' compliance programs.